Leprosy is one of the oldest diseases in the human record. Mentioned in ancient Egyptian papyri, condemned in biblical scripture, and used for centuries as justification for the forcible removal of the sick from their families and communities, it has carried a weight of fear and stigma far beyond its medical reality. Even today, in 2026, more than 200,000 new cases are reported every year across more than 120 countries. The disease remains active on every inhabited continent. The Americas alone account for approximately 13 percent of all reported global cases.

That context matters — because what Chile has just achieved is not the product of geography or luck. It is the product of thirty-three years of sustained, unflinching public health work.

On March 4, 2026, the World Health Organization — together with the Pan American Health Organization — announced that Chile has become the first country in the Americas, and only the second globally, to receive official WHO verification for the elimination of leprosy as a public health problem. Between 2012 and 2023, Chile reported just 47 cases nationwide — none of them locally acquired. The last domestically transmitted case was detected in 1993. WHO elimination is defined as zero new autochthonous cases for at least three consecutive years after interrupting transmission for at least five. Chile has exceeded that standard by decades.

This is an AMAZING moment because it proves that a disease with roots in recorded human history — one that isolated the sick, generated some of the most enduring social stigma in medicine, and resisted eradication in country after country — can be stopped. Not managed. Stopped. Chile becomes the 61st country in the world and the sixth in the Americas to eliminate at least one neglected tropical disease. That number — 61 — tells a story that rarely makes headlines: the quiet, methodical, unsexy work of public health, sustained year after year, produces results that are nothing short of historic.

Why does this matter to you? Leprosy has always been a disease of poverty. It thrives where healthcare is inaccessible, where stigma prevents diagnosis, and where political will evaporates in the face of more visible crises. Chile did not eliminate leprosy because the disease was never a threat there. It eliminated leprosy because it chose to build a public health infrastructure robust enough to find every case, treat every patient with free multi-drug therapy, and monitor every community until transmission stopped. That is a model, not a miracle. What Chile built is replicable — not everywhere at once, not without investment, but replicable. The 61 countries that have now eliminated at least one neglected tropical disease are not lucky. They are evidence that the work works.

The global picture remains serious, and it would be dishonest to pretend otherwise. More than 200,000 people will be diagnosed with leprosy this year. Brazil alone accounts for more than 90 percent of new cases in the Americas. Poverty, inadequate healthcare infrastructure, and persistent stigma continue to drive transmission across South Asia, sub-Saharan Africa, and parts of Latin America. Chile's achievement is a milestone — it is not a solution to the global challenge. The distance between one country's success and a world without the disease is vast, and it will only close through the same sustained, funded, politically supported commitment that Chile demonstrated across three decades.

The most powerful arguments against public health investment are the ones that ask why it should be a priority when so much else is urgent. Chile's WHO verification answers that question in the only language that cannot be argued with: data. Thirty-three years of sustained effort. Zero local transmission. Official elimination of one of the most ancient diseases in human memory. This did not happen because of a breakthrough drug or a single defining moment. It happened because a country decided it would not stop — and it did not. That is the model. That is the proof of concept. And it is available to every country that chooses to use it.

Sources: